Clinical Trial

German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 29, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The SCD-Q (Subjective Cognitive Decline-Questionnaire) is an established instrument to quantify self-perceived cognitive decline. Both self- and informant-rated versions of the SCD-Q are available. However, the SCD-Q has not been validated in the German language yet. Hence, the investigators aim to validate the self-reported SCD-Q in a clinical sample in Germany.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-27.
Trial Details
NCT Number NCT06711952
Lead Sponsor Ludwig-Maximilians - University of Munich
Collaborators: Medotrax UG
Conditions Alzheimer Disease, Subjective Cognitive Decline
Enrollment 300 participants
Start Date 2023-02-01
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-29